XLO icon

Xilio Therapeutics
XLO

Overview Fund Activity

28 hedge funds and large institutions have $42.8M invested in Xilio Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
7
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TOCUITCONY
1
Trustees of Columbia University in the City of New York
New York
$672K
2
Bank of America
2
Bank of America
North Carolina
$627K
3
BCM
3
Bridgeway Capital Management
Texas
$297K
4
Morgan Stanley
4
Morgan Stanley
New York
$68.9K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$100K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$5.13M
2
SCM
2
Soleus Capital Management
Connecticut
$610K
3
E
3
Ergoteles
New York
$0
4
RC
4
RBF Capital
California
$0
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.4M
Name Market Value Shares Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$7K 2,701 -3 -0.1%
UBS Group
27
UBS Group
Switzerland
$541 201 – –
Wells Fargo
28
Wells Fargo
California
$207 77 +2 +3%
E
29
Ergoteles
New York
– – -12,941 Closed
RC
30
RBF Capital
California
– – -10,072 Closed
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
1
2